Mohammad Reza Sobhiyeh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mohammad Reza Sobhiyeh has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
Saran Lotfollahzadeh
8 shared publicationsMohammad Mozafar
4 shared publicationsMohammad Mozaffar
General and Vascular Surgery Division, Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, IR Iran
4 shared publications- Barmak Gholizadeh
Department of General Surgery, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 shared publications Farideh Adhami
Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 shared publicationsSayena Jabbehdari
General and Vascular Surgery Division, Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, IR Iran
3 shared publications
Latest Publications
- Open Access
- 30 January 2025
- Published by DoNotEdit
- Vol. 1 (1) , 15-22
Exploring the Link Between Renal Failure Risk Factors and Arteriovenous Fistula Functionality in Dialysis Patients
In this study, we aim to investigate the relationship between a comprehensive set of risk factors for renal failure and the function of arteriovenous fistulas (AVFs) in dialysis patients. We will also explore the impact of potential confounders, such as age, sex, and comorbidities, on this relationship. This cross-sectional study was conducted at the dialysis unit of Imam Reza Hospital in Kermanshah, Iran, to examine the relationship between risk factors for renal failure and AVF function in dialysis patients. The study population consisted of patients with end-stage renal disease who required hemodialysis and had undergone AVF surgery. Patients were included if they met the following criteria: being over 18 years old, having undergone AVF surgery at least one year prior, and being willing to participate in the study. Patients with a history of AVF thrombosis, infection, or any other complications requiring surgical intervention during the follow-up period were excluded. A total of 85 patients with kidney failure undergoing hemodialysis were studied. The mean age of these patients was 57.89 ± 15.18 years. Approximately half of the dialysis patients (52.3%) were male. Most of the dialysis patients (95.3%) were in a desirable state. There was no significant relationship between AVF function and gender, indicating that the effectiveness or ineffectiveness of AVF was not related to gender (p=1). There was no significant statistical relationship between patient condition and AVF function (p=0.31). There was no significant statistical relationship between AVF function and diabetes status (p=0.48). There was no significant statistical relationship between AVF function and tobacco use status (p=1). By identifying and addressing factors that contribute to AVF dysfunction, healthcare providers can improve the quality of care for dialysis patients and reduce the need for more invasive procedures, such as central venous catheter placement.
- 30 January 2025
- Published by DoNotEdit
- Vol. 1 (1) , 15-22
Open AccessExploring the Link Between Renal Failure Risk Factors and Arteriovenous Fistula Functionality in Dialysis Patients
In this study, we aim to investigate the relationship between a comprehensive set of risk factors for renal failure and the function of arteriovenous fistulas (AVFs) in dialysis patients. We will also explore the impact of potential confounders, such as age, sex, and comorbidities, on this relationship. This cross-sectional study was conducted at the dialysis unit of Imam Reza Hospital in Kermanshah, Iran, to examine the relationship between risk factors for renal failure and AVF function in dialysis patients. The study population consisted of patients with end-stage renal disease who required hemodialysis and had undergone AVF surgery. Patients were included if they met the following criteria: being over 18 years old, having undergone AVF surgery at least one year prior, and being willing to participate in the study. Patients with a history of AVF thrombosis, infection, or any other complications requiring surgical intervention during the follow-up period were excluded. A total of 85 patients with kidney failure undergoing hemodialysis were studied. The mean age of these patients was 57.89 ± 15.18 years. Approximately half of the dialysis patients (52.3%) were male. Most of the dialysis patients (95.3%) were in a desirable state. There was no significant relationship between AVF function and gender, indicating that the effectiveness or ineffectiveness of AVF was not related to gender (p=1). There was no significant statistical relationship between patient condition and AVF function (p=0.31). There was no significant statistical relationship between AVF function and diabetes status (p=0.48). There was no significant statistical relationship between AVF function and tobacco use status (p=1). By identifying and addressing factors that contribute to AVF dysfunction, healthcare providers can improve the quality of care for dialysis patients and reduce the need for more invasive procedures, such as central venous catheter placement.
- 9 May 2024
- Published by Elsevier in Journal of Vascular Nursing
- Vol. 42 (3) , 154-158
Prevalence and risk factors associated with coronary artery disease in Iranian patients with peripheral artery disease
- 9 May 2024
- Published by Elsevier in Journal of Vascular Nursing
- Vol. 42 (3) , 154-158
Prevalence and risk factors associated with coronary artery disease in Iranian patients with peripheral artery disease
- Open Access
- 17 July 2023
- Published by Springer Nature in The Egyptian Journal of Internal Medicine
- Vol. 35 (1) , 1-11
A systematic review of the venous thromboembolism prevalence and related risk factors in patients with Covid-19
Introduction: The present study was performed to evaluate the pooled prevalence of the venous thromboembolism (VTE) and the factors affecting its incidence in patients who are affected with coronavirus disease (Covid-19). Patients and methods: A systematic review and meta-analysis were carried out by searching all the authentic online databases. The study includes papers worldwide since 2019 to 2022. After assessing related articles, the required information was collected based on a prepared checklist and analyzed by STATA software. Result: According to the estimates, pooled prevalence of VTE among patients with Covid-19 was 0.17 (95% CI = 0.13–0.22, P = 0.000). Analysis of prevalence values of VTE in patients with Covid-19 based on geographical areas showed statistically significant differences emerged from the study results. Analyses showed that stroke is a significant risk factor. Discussion: The present study showed a relatively high prevalence of VTE in patients infected with coronavirus. Results of study showed that prevalence of VTE is significantly differ according to geographical areas; it can be concluded that racial differences and genetic factors can affect the VTE incidence in Covid-19-affected patients. Additionally, a history of stroke and cerebrovascular events can be a risk factor indicating the need for prophylactic anticoagulant treatment in these patients, but history of respiratory disease, cardiovascular disease, hypertension, diabetes, dyslipidemia, liver disease, malignancy, and smoking is not risk factors of VTE in patients affected with Covid-19.
- 17 July 2023
- Published by Springer Nature in The Egyptian Journal of Internal Medicine
- Vol. 35 (1) , 1-11
Open AccessA systematic review of the venous thromboembolism prevalence and related risk factors in patients with Covid-19
Introduction: The present study was performed to evaluate the pooled prevalence of the venous thromboembolism (VTE) and the factors affecting its incidence in patients who are affected with coronavirus disease (Covid-19). Patients and methods: A systematic review and meta-analysis were carried out by searching all the authentic online databases. The study includes papers worldwide since 2019 to 2022. After assessing related articles, the required information was collected based on a prepared checklist and analyzed by STATA software. Result: According to the estimates, pooled prevalence of VTE among patients with Covid-19 was 0.17 (95% CI = 0.13–0.22, P = 0.000). Analysis of prevalence values of VTE in patients with Covid-19 based on geographical areas showed statistically significant differences emerged from the study results. Analyses showed that stroke is a significant risk factor. Discussion: The present study showed a relatively high prevalence of VTE in patients infected with coronavirus. Results of study showed that prevalence of VTE is significantly differ according to geographical areas; it can be concluded that racial differences and genetic factors can affect the VTE incidence in Covid-19-affected patients. Additionally, a history of stroke and cerebrovascular events can be a risk factor indicating the need for prophylactic anticoagulant treatment in these patients, but history of respiratory disease, cardiovascular disease, hypertension, diabetes, dyslipidemia, liver disease, malignancy, and smoking is not risk factors of VTE in patients affected with Covid-19.
- 1 March 2022
- Published by Elsevier in Journal of Vascular Nursing
- Vol. 40 (1) , 43-46
Ultrasonographic measurement of saphenous vein diameter compared to CEAP classification in patients with varicose veins
- 1 March 2022
- Published by Elsevier in Journal of Vascular Nursing
- Vol. 40 (1) , 43-46
Ultrasonographic measurement of saphenous vein diameter compared to CEAP classification in patients with varicose veins
- Open Access
- 10 November 2020
- Published by Wiley in Food Science & Nutrition
- Vol. 9 (1) , 303-312
The effect of yogurt co‐fortified with probiotic and vitamin D on lipid profile, anthropometric indices and serum 25‐hydroxi vitamin D in obese adult: A Double‐Blind Randomized‐ Controlled Trial
Vitamin D deficiency can be regarded as one of the overgrowing health problem in all of the world. Evidence from a clinical trial suggested a role for probiotic bacteria in increasing vitamin D. However, probiotic's effect is strain specific and this effect should be confirmed about different strains. The objective was to determine if yogurt fortification with probiotic bacteria, Lactobillus acidophilus La‐B5, Bifidobacterium lactis Bb‐12 either alone or in combination with vitamin D can be a complementary treatment for vitamin D deficiency. The end‐points were vitamin D, cardio metabolic lipid profile, anthropometric indices (weight, height, waist, hip, fat mass, lean body mass) and dietary intake. A 10‐week parallel‐group, double‐blind, randomized and controlled trial was conducted on 140 obese men and women. The participants were randomly allocated to receive 100 grams either 1) plain low‐fat yogurt or 2) probiotic yogurt or 3) vitamin D‐fortified yogurt or 4) probiotic and vitamin D cofortified yogurt. All groups received low‐calorie diet. Vitamin D increased significantly in group 4 (p = .008), group 3 (p = .001) and group 1 (p = .012 with no difference between groups. Vitamin D‐fortified yogurt had the most effect size and showed a significant difference versus plain (p = .018) and probiotic yogurt (p = .002). Regarding lipid profile, there were no significant differences between groups. Data from this study does not support the hypothesis that yogurt fortified with probiotic bacteria, Lactobillus acidophilus La‐5 and Bifidobacterium lactis Bb‐12 either alone or in combination with vitamin D might impose any increasing effect on serum level of vitamin D in comparison with vitamin D‐fortified yogurt.
- 10 November 2020
- Published by Wiley in Food Science & Nutrition
- Vol. 9 (1) , 303-312
Open AccessThe effect of yogurt co‐fortified with probiotic and vitamin D on lipid profile, anthropometric indices and serum 25‐hydroxi vitamin D in obese adult: A Double‐Blind Randomized‐ Controlled Trial
Vitamin D deficiency can be regarded as one of the overgrowing health problem in all of the world. Evidence from a clinical trial suggested a role for probiotic bacteria in increasing vitamin D. However, probiotic's effect is strain specific and this effect should be confirmed about different strains. The objective was to determine if yogurt fortification with probiotic bacteria, Lactobillus acidophilus La‐B5, Bifidobacterium lactis Bb‐12 either alone or in combination with vitamin D can be a complementary treatment for vitamin D deficiency. The end‐points were vitamin D, cardio metabolic lipid profile, anthropometric indices (weight, height, waist, hip, fat mass, lean body mass) and dietary intake. A 10‐week parallel‐group, double‐blind, randomized and controlled trial was conducted on 140 obese men and women. The participants were randomly allocated to receive 100 grams either 1) plain low‐fat yogurt or 2) probiotic yogurt or 3) vitamin D‐fortified yogurt or 4) probiotic and vitamin D cofortified yogurt. All groups received low‐calorie diet. Vitamin D increased significantly in group 4 (p = .008), group 3 (p = .001) and group 1 (p = .012 with no difference between groups. Vitamin D‐fortified yogurt had the most effect size and showed a significant difference versus plain (p = .018) and probiotic yogurt (p = .002). Regarding lipid profile, there were no significant differences between groups. Data from this study does not support the hypothesis that yogurt fortified with probiotic bacteria, Lactobillus acidophilus La‐5 and Bifidobacterium lactis Bb‐12 either alone or in combination with vitamin D might impose any increasing effect on serum level of vitamin D in comparison with vitamin D‐fortified yogurt.
- 1 September 2020
- Published by Galenos Yayinevi in Gulhane Medical Journal
- Vol. 62 (3) , 209-211
Endovascular extraction of a disconnected port-A catheter from inferior vena cava in a patient with chronic bilateral occlusion of femoroiliac veins: A case report
- 1 September 2020
- Published by Galenos Yayinevi in Gulhane Medical Journal
- Vol. 62 (3) , 209-211
Endovascular extraction of a disconnected port-A catheter from inferior vena cava in a patient with chronic bilateral occlusion of femoroiliac veins: A case report
- 1 December 2019
- Published by Elsevier in Journal of Vascular Nursing
- Vol. 37 (4) , 226-231
Comparison of foam sclerotherapy versus radiofrequency ablation in the treatment of primary varicose veins due to incompetent great saphenous vein: Randomized clinical trial
- 1 December 2019
- Published by Elsevier in Journal of Vascular Nursing
- Vol. 37 (4) , 226-231
Comparison of foam sclerotherapy versus radiofrequency ablation in the treatment of primary varicose veins due to incompetent great saphenous vein: Randomized clinical trial
- Open Access
- 8 June 2019
- Published by Biomedpress in Biomedical Research and Therapy
- Vol. 6 (6) , 3244-3247
Comparison of the efficacy of two types of hemodialysis catheters: the VectorFlow vs. Palindrome catheters
Introduction: Permanent vascular access via catheters is a critical factor for patients who need long-term hemodialysis. Differences in the design and mechanical factors can affect efficacy and survival of the permanent catheters. Modifications in the designs of the catheters can decrease the likelihood of damaging blood vessels as well as thrombosis formation and malfunction of the catheters. Objective: To compare survival of VectorFlow, complete symmetry of distal tip and offsetting of its side holes, with those of Palindrome, a complete symmetrical catheter. Methods: In this study, 146 CKD (chronic kidney disease) patients who required chronic hemodialysis were divided into VectrFlow (76 subjects) and Palindrome (70 subjects) catheter groups. The patients were followed for six months and the survival rate in each group was determined. Results: Mean (+/-SD) survival time in the VectorFlow catheter group (6.55+/-3.88 months, 2 to 24 months) was longer than in the Palindrome catheter group (5.22+/-2.88 months, one to 13 months). After six months, the VectorFlow catheter group (40 cases, 54.8%) had a higher number of patients, having a functioning catheter in place than the Palindrome group (26 cases, 382%); P= 0.04. Conclusion: The VectorFlow hemodialysis catheter had a better survival rate after 6 months when compared to the Palindrome catheter. We recommend using this catheter in CKD patients, who require a long-term permanent catheter.
- 8 June 2019
- Published by Biomedpress in Biomedical Research and Therapy
- Vol. 6 (6) , 3244-3247
Open AccessComparison of the efficacy of two types of hemodialysis catheters: the VectorFlow vs. Palindrome catheters
Introduction: Permanent vascular access via catheters is a critical factor for patients who need long-term hemodialysis. Differences in the design and mechanical factors can affect efficacy and survival of the permanent catheters. Modifications in the designs of the catheters can decrease the likelihood of damaging blood vessels as well as thrombosis formation and malfunction of the catheters. Objective: To compare survival of VectorFlow, complete symmetry of distal tip and offsetting of its side holes, with those of Palindrome, a complete symmetrical catheter. Methods: In this study, 146 CKD (chronic kidney disease) patients who required chronic hemodialysis were divided into VectrFlow (76 subjects) and Palindrome (70 subjects) catheter groups. The patients were followed for six months and the survival rate in each group was determined. Results: Mean (+/-SD) survival time in the VectorFlow catheter group (6.55+/-3.88 months, 2 to 24 months) was longer than in the Palindrome catheter group (5.22+/-2.88 months, one to 13 months). After six months, the VectorFlow catheter group (40 cases, 54.8%) had a higher number of patients, having a functioning catheter in place than the Palindrome group (26 cases, 382%); P= 0.04. Conclusion: The VectorFlow hemodialysis catheter had a better survival rate after 6 months when compared to the Palindrome catheter. We recommend using this catheter in CKD patients, who require a long-term permanent catheter.